Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics J. 2013 Aug;13(4):306-11. doi: 10.1038/tpj.2012.15. Epub 2012 May 29.

Predicting inhaled corticosteroid response in asthma with two associated SNPs.

Author information

  • 1Partners Healthcare Center for Personalized Genetic Medicine, Boston, MA, USA.

Abstract

Inhaled corticosteroids (ICS) are the most commonly used controller medications prescribed for asthma. Two single-nucleotide polymorphisms (SNPs), rs1876828 in corticotrophin releasing hormone receptor 1 and rs37973 in GLCCI1, have previously been associated with corticosteroid efficacy. We studied data from four existing clinical trials of asthmatics, who received ICS and had lung function measured by forced expiratory volume in 1 s (FEV1) before and after the period of such treatment. We combined the two SNPs rs37973 and rs1876828 into a predictive test of FEV1 change using a Bayesian model, which identified patients with good or poor steroid response (highest or lowest quartile, respectively) with predictive performance of 65.7% (P=0.039 vs random) area under the receiver-operator characteristic curve in the training population and 65.9% (P=0.025 vs random) in the test population. These findings show that two genetic variants can be combined into a predictive test that achieves similar accuracy and superior replicability compared with single SNP predictors.

PMID:
22641026
[PubMed - indexed for MEDLINE]
PMCID:
PMC3434304
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk